Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and δtor activation

Psychopharmacology

Volumn 217, Issue 3, 2011, Pages 377-386

  Ago, Yukio ^a   Yano, Koji ^a   Hiramatsu, Naoki ^a   TakuM A , Kazuhiro ^a   Matsuda, Toshio ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

1 receptor; Adrenalectomy castration; C Fos; Dopamine (DA); Fluvoxamine; Prefrontal cortex

Indexed keywords

DOPAMINE; FLUVOXAMINE; MONOAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; NORADRENALIN; PAROXETINE; PROTEIN C FOS; SEROTONIN; SIGMA OPIATE RECEPTOR; SKF 10 047; UNCLASSIFIED DRUG;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CASTRATED MALE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG PROTEIN BINDING; DRUG TARGETING; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN UPTAKE; SHAM PROCEDURE; UPREGULATION;

ADRENALECTOMY; ANIMALS; DOPAMINE; ETHYLENEDIAMINES; FLUVOXAMINE; MALE; MICE; MICE, INBRED STRAINS; NOREPINEPHRINE; ORCHIECTOMY; PHENAZOCINE; PREFRONTAL CORTEX; RECEPTORS, SEROTONIN; RECEPTORS, SIGMA; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 82955182193     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2293-5     Document Type: Article

References (57)

1. Ago Y, Koyama Y, Baba A, Matsuda T (2003) Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45:1050-1056 (Pubitemid 37412250)
2. Ago Y, Nakamura S, Baba A,Matsuda T (2005) Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. Neuropsychopharmacology 30:43-51 (Pubitemid 40024398)
3. Ago Y, Nakamura S, Kajita N, Uda M, Hashimoto H, Baba A,Matsuda T (2007) Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse 61:757-763 (Pubitemid 47122748)
4. Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K, Matsuda T (2009) Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamineinduced hyperactivity. Synapse 63:7-14
5. Artigas F (2010) The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatr Scand 121:11-21
6. Barrett-Connor E, von Mühlen D, Laughlin GA, Kripke A (1999) Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc 47:685-691 (Pubitemid 29266635)
7. Barrot M, Valleacute;e M, Gingras MA, Le Moal M, Mayo W, Piazza PV (1999) The neurosteroid pregnenolone sulphate increases dopamine release and the dopaminergic response to morphine in the rat nucleus accumbens. Eur J Neurosci 11:3757-3760 (Pubitemid 29484271)
8. Bermack JE, Debonnel G (2005) The role of sigma receptors in depression. J Pharmacol Sci 97:317-336 (Pubitemid 40515745)
9. Berr C, Lafont S, Debuire B, Dartigues JF, Baulieu EE (1996)Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93:13410-13415 (Pubitemid 26382830)
10. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW (2002) Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology 160:353-361 (Pubitemid 34253277)
11. Castro E, Tordera RM, Hughes ZA, Pei Q, Sharp T (2003) Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist co-administration. J Neurochem 85:1480-1487 (Pubitemid 36702560)
12. Cobos EJ, Entrena JM, Nieto FR, Cendaacute;n CM, Del Pozo E (2008) Pharmacology and therapeutic potential of sigma1 receptor ligands. Curr Neuropharmacol 6:344-366
13. Corpéchot C, Young J, Calvel M, Wehrey C, Veltz JN, Touyer G, Mouren M, Prasad VVK, Banner C, Sjovall J, Baulieu EE, Robel P (1993) Neurosteroids: 3α-hydroxy-5α-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133:1003-1009 (Pubitemid 23267748)
14. Del Arco A, Mora F (2009) Neurotransmitters and prefrontal cortex- limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 116:941-952
15. Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 61(Suppl 6):7-11 (Pubitemid 30217405)
16. Delgado PL, Moreno FA (2000) Role of norepinephrine in depression. J Clin Psychiatry 61(Suppl 1):5-12 (Pubitemid 30124144)
17. Egashira N, Harada S, Okuno R, Matsushita M, Nishimura R, Mishima K, Iwasaki K, Orito K, Fujiwara M (2007) Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine. Eur J Pharmacol 563:149-154 (Pubitemid 46602243)
18. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
19. George MS, Guidotti A, Rubinow D, Pan B, Mikalauskas K, Post RM (1994) CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI. Biol Psychiatry 35:775-780 (Pubitemid 24164999)
20. Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38:315-317 (Pubitemid 29073553)
21. Hardoy MC, Serra M, Carta MG, Contu P, Pisu MG, Biggio G (2006) Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder. J Clin Psychopharmacol 26:379-384 (Pubitemid 44187639)
22. Hashimoto K, Fujita Y, Iyo M (2007) Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 32:514-521
23. Hayashi T, Su TP (2004) σ-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18:269-284 (Pubitemid 38526712)
24. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M (1999) Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res 89:97-106
25. Hindmarch I, Hashimoto K (2010) Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered. Hum Psychopharmacol 25:193-200
26. Huang M, Ichiwaka J, Li Z, Dai J, Meltzer HY (2006) Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology 185:274-281
27. 11C]SA4503. Biol Psychiatry 62:878-883 (Pubitemid 47488223)
28. Izumi T, Inoue T, Kitaichi Y, Nakagawa S, Koyama T (2006) Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur J Pharmacol 534:129-132 (Pubitemid 43384193)
29. Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A, Izumi T, Koyama T (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 647:90-96
30. Kobayashi T, Matsuno K, Murai M, Mita S (1997) δ or subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochem Res 22:1105-1109 (Pubitemid 27327936)
31. Koda K, Ago Y, Cong Y, Kita Y, Takuma K, Matsuda T (2010) Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice. J Neurochem 114:259-270
32. Kovaacute;cs KJ (2008) Measurement of immediate-early gene activationc- fos and beyond. J Neuroendocrinol 20:665-672
33. Matsumoto M, Togashi H, Mori K, Ueno K, Miyamoto A, Yoshioka M (1999) Characterization of endogenous serotonin-mediated regulation of dopamine release in the rat prefrontal cortex. Eur J Pharmacol 383:39-48 (Pubitemid 29509820)
34. Maurice T, Urani A, Phan VL, Romieu P (2001) The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev 37:116-132 (Pubitemid 34020726)
35. Meltzer HY, Huang M (2008) In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog Brain Res 172:177-197
36. Michael A, Jenaway A, Paykel ES, Herbert J (2000) Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol Psychiatry 48:989-995
37. Narita N, Hashimoto K, Tomitaka S, Minabe Y (1996) Interactions of selective serotonin reuptake inhibitors with subtypes of σ receptors in rat brain. Eur J Pharmacol 307:117-119 (Pubitemid 26226293)
38. Nishimura T, Ishima T, Iyo M, Hashimoto K (2008) Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. PLoS ONE 3:e2558
39. Paslakis G, Luppa P, Gilles M, Kopf D, Hamann-Weber B, Lederbogen F, Deuschle M (2010) Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosteronesulfate in depressed patients remitting during the course of treatment. J Psychiatr Res 44:556-560
40. Phan VL, Su TP, Privat A, Maurice T (1999) Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect σ1 receptor-mediated behaviour in mice. Eur J Neurosci 11:2385-2396 (Pubitemid 29292333)
41. Phan VL, Urani A, Romieu P, Maurice T (2002) Strain differences in σ1 receptor-mediated behaviours are related to neurosteroid levels. Eur J Neurosci 15:1523-1534 (Pubitemid 35477983)
42. Phan VL, Urani A, Sandillon F, Privat A, Maurice T (2003) Preserved sigma1 (σ1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse. Neurobiol Aging 24:865-881 (Pubitemid 37288860)
43. Redrobe JP, Bourin M (1998) Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Psychopharmacology 138:198-206 (Pubitemid 28330838)
44. Renard CE, Fiocco AJ, Clenet F, Hascoet M, Bourin M (2001) Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test? Psychopharmacology 159:42-50 (Pubitemid 34031249)
45. Rhodes ME, Li PK, Flood JF, Johnson DA (1996) Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res 733:284-286 (Pubitemid 26308606)
46. Schüle C, Baghai TC, Eser D, Schwarz M, Bondy B, Rupprecht R (2009) Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients. J Psychiatr Res 43:538-545
47. Sharp JW (1997) Phencyclidine (PCP) acts at σ sites to induce c-fos gene expression. Brain Res 758:51-58 (Pubitemid 27310642)
48. Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CT (2009) Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 57:415-424
49. Urani A, Roman FJ, Phan VL, Su TP, Maurice T (2001) The antidepressant-like effect induced by σ1-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther 298:1269-1279 (Pubitemid 32761949)
50. Veening JG, Coolen LM, Spooren WJ, Joosten H, van Oorschot R, Mos J, Ronken E, Olivier B (1998) Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration. Eur Neuropsychopharmacol 8:213-226 (Pubitemid 28334183)
51. Volonteacute; M, Ceci A, Borsini F (1995) Effect of the 5- hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study. J Pharmacol Exp Ther 275:358-367
52. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H (1997) Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 41:311-318 (Pubitemid 27095256)
53. Wolkowitz OM, Reus VI, Keebler A, Nelson N, FriedlandM, BrizendineL, Roberts E (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156:646-649 (Pubitemid 29162992)
54. Yaffe K, Ettinger B, Pressman A, Seeley D, Whooley M, Schaefer C, Cummings S (1998) Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study. Biol Psychiatry 43:694-700 (Pubitemid 28222391)
55. Yamada M, Nakao S, Sakamoto S, Takamori Y, Tamura Y, Mochizuki-Oda N (2006) Propofol acts at the sigma-1 receptor and inhibits pentazocine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices. Acta Anaesthesiol Scand 50:875-881 (Pubitemid 44034240)
56. Zhang W, Perry KW, Wong DT, Potts BD, Bao J, Tollefson GD, Bymaster FP (2000) Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex. Neuropsychopharmacology 23:250-262 (Pubitemid 30609659)
57. Zheng P (2009) Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 89:134-152